DISCOUNT ZERTIFIKAT - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 12:59:44 2024-06-20 pm EDT | ||
| 40.41 EUR | +0.87% |
|
| Current month | +1.74% | ||
| 1 month | +2.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 40.41 | +0.87% |
| 24-06-19 | 40.06 | -0.55% |
| 24-06-18 | 40.28 | +0.07% |
| 24-06-17 | 40.25 | -0.35% |
| 24-06-14 | 40.39 | +0.35% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 12:59 pm EDT
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Morgan Stanley |
| WKN | MG1CPJ |
| ISIN | DE000MG1CPJ0 |
| Date issued | 2024-04-02 |
| Maturity | 2025-03-21 (274 Days) |
| Parity | 1 : 1 |
| Emission price | 39.87 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.41 € |
|---|---|
| Lowest since issue | 39.04 € |
| Spread | 0.01 € |
| Spread % | 0.02% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77
USD
Average target price
82.26
USD
Spread / Average Target
+6.83%
- Stock Market
- Certificates
- Certificat
